U

Upstream Bio Inc
D

UPB

19.980
USD
-0.10
(-0.50%)
مغلق
حجم التداول
9,146
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
1,077,110,351
المقالات

العنوان: Upstream Bio Inc

القطاع: Healthcare
الصناعة: Biotechnology
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.